Virtual Rounds 2022 Program
Cardiology Track |
Heart Failure: The Multiverse of Therapy Lauren Eyadiel, PA-C From the 1980s through the early 2000s, there was little medical innovation in the field of heart failure therapies. But in 2014, angiotensin and neprilysin inhibitors were introduced and medical therapy in heart failure has been booming ever since.
Cardiology PA Lauren Eyadiel will present on these new therapies with the objective to:
|
Valvular Heart Disease Lyle W. Larson, PhD, PA-C, DFAAPA As many as 11.6 million Americans have heart valve disease, and it is not limited to just adults. Congenital heart disease frequently includes valvular defects and affects 40,000 births a year in the U.S. PAs will commonly encounter valvular heart disease in their practices regardless of specialty. It is imperative that they know how to differentiate between benign and potentially lethal outcomes. Participants in this session will learn:
|
Time is Tissue: Leveraging the Latest ACC/AHA 2021 Chest Pain Guidelines Viet Le, MPAS, PA-C, FACC, FAHA Cardiovascular disease (CVD) has been and still is the leading cause of adult deaths in the US. In the course of treating acute and chronic CVD, patients often receive multiple new medications and recommendations for post-hospital rehabilitation that is sometimes overwhelming. PAs can facilitate optimal recovery by implementing guideline-directed therapies for both acute and chronic CVD. Participants of this course will:
|
What You Should Really Know About Peripheral Arterial Disease (PAD) Robert Ross, PA-C What has increasingly been recognized is that if an individual has blocked arteries in the legs, they are also very likely to have blocked arteries in the heart and the brain. Peripheral Arterial Disease (PAD) is a very strong independent predictor of having heart attacks and strokes and so it deserves attention for that reason alone. Orchestrated efforts among healthcare providers, researches, expert organizations, and healthcare organizations will be needed to increase awareness and understanding of PAD and improve the diagnostic approaches, management, and prognosis of PAD. In this lecture, cardiology and endocrinology expert Robert Ross, PA-C, will cover the following to help primary care providers develop an excellent cardiovascular prevention program for all their at-risk patients:
|